712.50
+0(+0.00%)
Currency In GBp
Address
25 Norman Way
Cambridge, CB24 5QE
United Kingdom of Great Britain and Northern Ireland
Phone
44 1223 967 943
Website
Sector
Healthcare
Industry
Biotechnology
Employees
101
First IPO Date
February 17, 2021
| Name | Title | Pay | Year Born |
| Dr. Heikki Lanckriet Ph.D. | Chief Executive Officer, Chief Scientific Officer & Executive Director | 526,200 | 1977 |
| Dr. Amy Walker | Chief Operating Officer & Director | 308,030 | N/A |
| Mr. David Roth | Chief Financial Officer, Company Secretary & Executive Director | 377,800 | 1967 |
| Dr. Manja Hermina Elisabeth Maria Boerman Ph.D. | Executive Chair of the Board | 0 | 1966 |
4basebio PLC engages in the design, development, manufacturing, and supply of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company provides research kits, bulk enzymes, and other products, as well as licensing services; and AVV manufacturing services. It serves biotech, pharma, and contract development and manufacturing organization customers. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was incorporated in 2020 and is based in Cambridge, United Kingdom.